|
Symbol
|
PMWLTQ | Z093XZ | OCJRCH | IHTEFG | HZJEFG | RMBFAV | OOIRCH | RLOALV | Z09YGZ | PBURCH | RMA3QV | RMBRKV | ERORCH | PEIRCH | ABMUTQ | PJIRCH | AZFBIL | PRZRCH | Z0ARNZ | CQWBKB |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Multi Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Worst of Callable Reverse Convertible | Reverse Convertible | Reverse Convertible | Multi Vonti | Worst of Callable Reverse Convertible | Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Worst of Callable Reverse Convertible | Multi Vonti | Reverse Convertible | Worst of Callable Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Worst of Callable Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Autocallable Reverse Convertible Defensive worst | Reverse Convertible |
|
Basiswert
|
Amgen Inc. / Lonza Group N / Novartis Sandoz Basket / Pfizer Inc. / Roche AG | Lonza Group N / Tecan Group AG / Ypsomed Hldg. AG | Kühne & Nagel Intl. AG / Lonza Group N / Sandoz Group AG | Compagnie Financière Richemont SA / Lonza Group N / Sonova Hldg. AG / Swiss RE AG / Swisscom N | Lonza Group N / Roche GS / Sika AG | Kühne & Nagel Intl. AG / Lonza Group N / Sika AG | Holcim/Amrize Basket / Kühne & Nagel Intl. AG / Lonza Group N / VAT Group | Lonza Group N | Compagnie Financière Richemont SA / Lonza Group N / Schindler PS / Sika AG | Alcon / Lonza Group N / Sandoz Group AG | Alcon / Lonza Group N / Novartis AG / Roche AG / Sandoz Group AG | Bucher Industries AG / Lonza Group N / Sika AG | BKW AG / Kühne & Nagel Intl. AG / Lonza Group N | Lonza Group N / Novartis AG / Roche AG / Sandoz | Clariant AG / Comet Hldg. AG / Lonza Group N / OC Oerlikon N / Swatch Group I | Bachem Hldg. AG / Lonza Group N / Ypsomed Hldg. AG | Companie Financière Richemont SA / Julius Baer Group / Lonza Group N | Lonza Group N / Swiss Life Hldg. N / Swiss RE AG | Holcim/Amrize Basket / Lonza Group N / Sandoz Group AG | Lonza Group N / Novartis N / Roche GS / Straumann Hldg. AG |
|
Emittent
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fälligkeit
|
09.02.2026 | 19.02.2026 | 08.04.2026 | 28.06.2029 | 02.11.2026 | 13.07.2026 | 15.01.2026 | 30.12.2025 | 27.08.2027 | 21.07.2026 | 09.11.2026 | 05.11.2026 | 06.11.2026 | 11.11.2026 | 20.12.2029 | 16.06.2026 | 04.02.2026 | 24.02.2027 | 25.08.2026 | 13.03.2028 |
| Ratio | - | - | - | - | - | - | - | 0,09944 | - | - | - | - | - | - | - | - | - | - | - | - |
|
Ausübungs-Preis
|
401.66 | 357.44 | 192.6425 | 90.3175 | 364.182 | 208.20 | 334.88 | 497.20 | 386.538 | 367.64 | 66.84 | 277.60 | 350.09 | 66.843 | 171.275 | 250.58 | 447.90 | 416.78 | 76.4918 | 78.705 |
|
Maximal- rendite p.a. |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Geld | - | - | - | - | 85.97 | 74.80 | 95.23 | 99.70 | - | - | 97.50 | 91.90 | - | 99.46 | 80.04 | 97.66 | 100.81 | 97.60 | - | 95.50 |
| Brief | - | - | - | - | - | 75.60 | 96.03 | 100.30 | - | - | 98.30 | 92.70 | - | 100.26 | 80.84 | 98.46 | 101.62 | 98.40 | - | 96.30 |